House Committee Report
Underlined text would be added to current law. Struck-through text would be removed.
| By: Blanco, et al. | S.B. No. 1098 | |
| (Hull) | ||
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to the disclosure by a pharmacy to a patient of certain | |
| price information for a drug or biological product. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Section 562.003, Occupations Code, is amended to | |
| read as follows: | |
| Sec. 562.003. DISCLOSURE OF PRICE; PATIENT'S OPTION. (a) A | |
| pharmacy shall disclose the lowest cost cash price at that pharmacy | |
| for the drug or biological product prescribed to the patient. | |
| (b) If the price of a drug or biological product to a patient | |
| is lower than the amount of the patient's copayment under the | |
| patient's prescription drug insurance plan, the pharmacist shall | |
| offer the patient the option of paying for the drug or biological | |
| product at the lower price instead of paying the amount of the | |
| copayment. | |
| SECTION 2. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.